Records containing: Lymphoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-07-17Biospecimen Collection and Donation to the AIDS and Cancer Specimen Resource (ACSR): A Companion Protocol to AMC Trials
-
CLINICAL_TRIALS study record update · 2025-07-17Mediastinal Endobronchial Ultrasound Bronchoscopy Cryobiopsy Study In Sweden
-
CLINICAL_TRIALS study record update · 2025-07-14A Phase 2, Single-Arm, Open-Label, Multicenter Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in the Frontline Treatment of Chinese Patients With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)
-
CLINICAL_TRIALS study record update · 2025-07-11Pilot Trial of Telehealth Music Therapy for Cognitive Dysfunction in Hematologic Cancer Survivors (PRELUDE)
-
CLINICAL_TRIALS study record update · 2025-07-08A Single Centre Cohort Study to Determine if Clonal Hematopoieses of Indeterminate Potential (CHIP) is a Risk Factor for Chemotherapy-Related Complications in Lymphoma Patients >= 60 Receiving Cytotoxic Chemotherapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-07-08Use of [F-18] FLT for Imaging With Positron Emission Tomography (PET)
-
CLINICAL_TRIALS study record update · 2025-07-03A Phase 1 First-in-human Dose-escalation and Dose-expansion Study of BMF-219, an Oral Covalent Menin Inhibitor, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL)
-
CLINICAL_TRIALS study record update · 2025-07-03A Randomized, Open Label Pilot Trial of a Biomarker Guided Strategy of Cardioprotection in Patients With Lymphoma or Breast Cancer Treated With Anthracyclines
-
CLINICAL_TRIALS study record update · 2025-07-02Clinical Study on the Safety and Efficacy of Chimeric Antigen Receptor Gene Modified T Cells Targeting CD30 in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2025-07-02Phase 1/1b Study of the Safety of TTX-030 as a Single Agent and in Combination With Pembrolizumab or Chemotherapy in Patients With Lymphoma or Solid Tumor Malignancies
-
CLINICAL_TRIALS study record update · 2025-07-01Expectations and Priorities of Elderly Patients for a First Medical Treatment for Cancer : PRIORITY Study
-
CLINICAL_TRIALS study record update · 2025-06-29PH-139: A Phase I Safety and Pharmacokinetic Study of Gamitrinib Administered Intravenously to Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2025-06-27Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
-
CLINICAL_TRIALS study record update · 2025-06-26A Phase 1, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-689 in Patients With Relapsed or Refractory Lymphoma
-
CLINICAL_TRIALS study record update · 2025-06-26Diagnosis Of Lymphoma In Vivo Using Vibrational Spectroscopy (In Vivo Phase)
-
CLINICAL_TRIALS study record update · 2025-06-25Carolina Senior: UNC Registry for Older Cancer Patients
-
CLINICAL_TRIALS study record update · 2025-06-24The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
-
CLINICAL_TRIALS study record update · 2025-06-24Myeloablative Allogeneic Hematopoietic Cell Transplantation Using a Related or Unrelated Donor for the Treatment of Hematological Diseases
-
CLINICAL_TRIALS study record update · 2025-06-22A Prospective Study for Patients With Lymphoma at the Samsung Medical Center
-
CLINICAL_TRIALS study record update · 2025-06-17An Open-Label, Dose-Finding and Proof of Concept Study of the PD-L1 Probody® Therapeutic , CX-072, as Monotherapy and in Combination With Yervoy (Ipilimumab) or With Zelboraf (Vemurafenib) in Subjects With Advanced or Recurrent Solid Tumors or Lymphomas
-
CLINICAL_TRIALS study record update · 2025-06-17Early Assessment of Aggressive B-Cell Lymphoma Treatment Response and Prediction of Recurrence Using Phased Variant Analysis With Next-Generation Sequencing
-
CLINICAL_TRIALS study record update · 2025-06-15Identification and Evaluation of Patients at Risk of Developing Cardiotoxicity After Receiving Chemotherapy for Breast Cancer, Lymphoma or Leukemia
-
CLINICAL_TRIALS study record update · 2025-06-13The PACMAN-hu19 Trial: a Phase I/II Study to Investigate the Safety and Feasibility of Point-of-care Human CD19 Targeting CAR T-cells in Pediatric and Young Adult Patients With Relapsed or Refractory B-cell Malignancies
-
CLINICAL_TRIALS study record update · 2025-06-12The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco-hematologic Disease (Onco-hema Go Wish-ACP): Intervention Set up and Multicentre Feasibility Trial
-
CLINICAL_TRIALS study record update · 2025-06-11The Value of Monitoring Circulating Cell DNA (ctDNA) in Pediatric Lymphoma: A Prospective, Multicenter Clinical Study